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Three PCR techniques (amplification of the psaA, ply, and lytA genes) and a commercial kit (AccuProbe
[GenProbe, San Diego, Calif.], based on hybridization with the 16S rRNA gene), all four of which claimed to
be specific for Streptococcus pneumoniae, were used to identify 49 alpha-hemolytic streptococcal isolates sus-
pected of being pneumococci. The definite phenotypic identification of these organisms as S. pneumoniae was
difficult when optochin susceptibility and the presence of a capsule were taken as markers. Furthermore, RsaI
digestion of the amplified 16S rRNA gene was applied. All 49 strains were optochin resistant. Eleven of these
were encapsulated and were identified as pneumococci by all tests. Twenty of the 38 unencapsulated strains
were unambiguously identified as nonpneumococci by all tests. The identities of another 18 unencapsulated
strains remained inconclusive due to highly variable reactions for all phenotypic and genotypic techniques
applied. The AccuProbe test was positive for seven strains for which the results of the other tests were incon-
clusive. RsaI restriction of the amplified 16S rRNA gene confirmed the AccuProbe result for all strains, while
the result of the psaA-specific PCR was in concordance with encapsulation for all strains. The results presented
here indicate that identification problems continue to exist for some strains, despite the application of
genotypic and phenotypic tests in combination. We found the psaA-specific PCR to be the genotypic technique
best suited for the identification of genuine pneumococci and optochin-resistant pneumococci.
Optochin susceptibility and encapsulation are the pheno-
typic characteristics that are the most frequently used to dif-
ferentiate between Streptococcus pneumoniae and other strep-
tococci (22). However, optochin-resistant S. pneumoniae strains
are being isolated more frequently (2, 29) and are probably
largely overlooked, since in many laboratories primary isola-
tion of pneumococci on culture medium relies on optochin
susceptibility itself. The occasional occurrence of encapsulated
S. mitis and S. oralis strains and the fact that nontypeable,
unencapsulated pneumococci have been reported to comprise
2% of the isolates from normally sterile sites (3) and up to 20%
of the conjunctival isolates (12) further complicate the identi-
fication of pneumococci. Commercial systems like the API 20S
and Vitek2 systems occasionally fail to identify pneumococcal
isolates or identify other streptococci as pneumococci (4).
Thus, even though the phenotypic identification of typical
pneumococci is unambiguous, the existence of optochin-resis-
tant isolates may increasingly cause problems in clinical bac-
teriological laboratories.
In the last decade, new gene amplification methods, based
on the detection of pneumococcal virulence factors, have been
developed to identify pneumococcal strains (18, 23, 24, 34) and
to detect pneumococci directly from clinical samples (8, 13, 14,
19, 31–33, 35, 36). Hybridization methods (10, 30) have also
been used for the identification of pneumococci. A commer-
cial hybridization method (AccuProbe; GenProbe, San Diego,
Calif.) that is based on the complementarity of a DNA probe
with the 16S rRNA of S. pneumoniae is increasingly being used
(6) in clinical laboratories.
Our aim was to evaluate recently described genotypic meth-
ods for their abilities to identify pneumococci. We tested the
applicabilities of the commercial AccuProbe test and of enzy-
matic amplification of three different genes, those encoding
pneumolysin (ply) (31), pneumococcal surface antigen A
(psaA) (24), and autolysin (lytA) (23), for the identification of
49 optochin-resistant pneumococcus-like strains that were sent
to the Reference Laboratory for Pneumococcus (KTL), Na-
tional Public Health Institute, Oulu, Finland, during the last
few years. In addition, RsaI restriction digestion of the ampli-
fied 16S rRNA gene (rDNA) (amplified rDNA restriction
analysis [ARDRA]) was carried out (5, 16).
MATERIALS AND METHODS
Bacterial strains. The following reference strains were used: S. pneumoniae
LMG 14545T, LMG 15155, LMG 16738, GUH S91 01273, GUH H91 04493,
GUH 93 08 1310, GUH 93 0 3230, GUH 93 09 1111, GUH 98 10 1630, GUH 98
10 3326, and GUH 98 10 3367; S. mitis LMG 14557T, LMG 14553, LMG 14552,
GUH 94 03 0728, GUH 94 04 0401, GUH 97 03 2943, GUH 98 05 5898, GUH
98 07 1207, GUH 98 09 0066, KTL 101, KTL 102, and KTL 103; S. oralis LMG
14532T, LMG 14533, LMG 14534, GUH 94 08 5574, GUH 98 05 5050, and GUH
98 10 1512; and S. sanguinis LMG 14656 and LMG 14657. Table 1 lists the 49
optochin-resistant alpha-hemolytic streptococcal isolates included in this study.
These strains were originally identified as pneumococci or suspected of being
pneumococci on the basis of the results of the optochin susceptibility test and
evaluation of their colony morphologies, performed in routine clinical laborato-
ries. They were sent to the reference laboratory (KTL) for identification and
serotyping because they were isolated from blood or cerebrospinal fluid or
because they were not fully susceptible to penicillin. They were included in
this study because they were found to be optochin resistant in the reference
laboratory.
Phenotypic assays. Optochin resistance testing, the tube bile solubility test,
and the capsular swelling test (the Quellung reaction) were performed as de-
scribed by Kaijalainen et al. (17). Briefly, after four commercially available tests
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for optochin susceptibility were compared, it was decided to use the result
obtained with the Biodisk (Biodisk PDM Diagnostic Disks, Solna, Sweden) as
the result of record. Bile solubility was tested by the method described by
Facklam and Washington (9). The Quellung reaction test was performed as
described by Austrian (1).
AccuProbe test. DNA hybridization with S. pneumoniae-specific 16S rRNA
sequences was performed by using the AccuProbe S. pneumoniae culture iden-
tification test (GenProbe) according to the instructions of the manufacturer (17).
PCR assays. Amplification of the pneumolysin (ply) gene fragment was per-
formed as described by Rintama¨ki et al. (31). Briefly, one pneumococcal colony
TABLE 1. Phenotypic and genotypic identification results for 49 optochin-resistant alpha-hemolytic pneumococcus-like Streptococcus spp.
Group and study
isolate no.
Original
isolate no.
AccuProbe
result
Capsule
formation
PCR result ARDRA
patterna
Bile
solubilitypsaA lytA ply
Group I
STR119 KTL 004      p 
STR120 KTL 005      ND 
STR125 KTL 013      p 
STR127 KTL 017      ND 
STR141 KTL 043      p 
STR144 KTL 051      ND 
STR147 KTL 056      ND 
STR149 KTL 063      p 
STR155a KTL 076      ND 
STR163 KTL 091      ND 
STR164 KTL 093      ND 
Group IIa
STR157 KTL 079    wb  p 
STR148b KTL 062b    w  p 
STR150 KTL 065    w  p 
STR162 KTL 089      p 
STR165 KTL 096    w  p 
STR142b KTL 046b      p 
STR146b KTL 055b  wc    p 
Group IIb
STR122 KTL 007      m 
STR133 KTL 028      ND 
STR126b KTL 016b    w  m 
STR129 KTL 020    w  m 
STR130 KTL 021      ND 
STR137 KTL 035    w  m 
STR152 KTL 069    w  m 
STR153 KTL 072      m 
STR166b KTL 099b      m 
STR131 KTL 022    w  m 
STR151 KTL 068      ND 
Group IIc
STR118 KTL 003      ND 
STR121 KTL 006      ND 
STR136 KTL 034      ND 
STR138 KTL 038      ND 
STR145 KTL 054      ND 
STR154 KTL 073      ND 
STR123 KTL 008      ND 
STR128 KTL 019      m 
STR132 KTL 023      ND 
STR134 KTL 029      ND 
STR139 KTL 039      m 
STR158 KTL 081      ND 
STR159 KTL 083      ND 
STR156 KTL 077      m 
STR117 KTL 002      ND 
STR140 KTL 041      ND 
STR160 KTL 085      ND 
STR161 KTL 087      ND 
STR135 KTL 030  w    m 
STR143 KTL 050  w    m 
a ARDRA, PCR-based amplification of the 16S rRNA-gene followed by RsaI digestion, agarose electrophoresis, and ethidium bromide staining. m, S. mitis-specific
pattern, p, S. pneumoniae-specific pattern, ND, not determined.
b Weak band after agarose gel electrophoresis and ethidium bromide staining.
c Weak capsule reaction, with the strain considered unencapsulated.
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was suspended in 100 l of the PCR mixture, and primers WO506 (5-biotin-C
CCACTCTTCTTGCGGTTGA) and WO507 (5-TGAGCCGTTATTTTTTCA
TACTG) amplified a 209-bp region of the pneumolysin gene.
Amplification was done with the following PCR program: predenaturation for
10 min at 94°C; 30 cycles of 30 s at 94°C, 30 s at 55°C, and 30 s at 72°C; and
postextension for 6 min at 72°C. The amplification products were identified by
agarose gel electrophoresis with ethidium bromide staining and were confirmed
by solution hybridization with a europium-labeled probe.
For amplification of the pneumococcal surface antigen A (psaA) gene and the
autolysin (lytA) gene, DNA was extracted by alkaline lysis, which was carried out
by suspending one colony in 20 l of 0.25% sodium dodecyl sulfate–0.05 N
NaOH and heating of the mixture at 95°C for 15 min, followed by a final dilution
with 180 l of distilled water.
Part of the psaA gene (838 bp) was amplified with 1.6 M each primers psaA1
(5-CTT TCT GCA ATC ATT CTT G) and psaA2 (5-GCC TTC TTT ACC
TTG TTC TGC), designed by Morrison et al. (24). Amplification was performed
in a reaction mixture of 10 l containing 5 l of PCR Master Mix (Promega
Benelux, Leiden, The Netherlands) and 1 l of the DNA extract in a GeneAmp
PCR System 9600 instrument (Applied Biosystems, Foster City, Calif.) by using
the following cycling parameters: 95°C for 5 min, followed by 30 cycles of 30 s at
94°C, 30 s at 52°C, and 2 min at 72°C, with a final extension for 8 min at 72°C.
One micromolar each of primers lytAF (5-ACG CAA TCT AGC AGA TGA
AGC) and lytAR (5-TGT TTG GTT GGT TAT TCG TGC), designed by
McAvin et al. (23), were used to amplify a 101-bp fragment of the lytA gene. The
cycling parameters for the lytA gene were 95°C for 5 min, followed by 35 cycles
of 30 s at 95°C, 30 s at 60°C, and 30 s at 72°C, with a final extension at 72°C for
8 min.
The presence of psaA and lytA amplification products was checked by electro-
phoresis on 2% agarose gels stained with ethidium bromide.
ARDRA. ARDRA, i.e., amplification of the 16S rRNA gene and subsequent
restriction digestion with RsaI followed by agarose electrophoresis, was carried
out as described previously (5, 16).
RESULTS
A set of three phenotypic and five genotypic identification
techniques was carried out with a total of 78 Streptococcus mitis
group strains, comprising 12 S. mitis, 6 S. oralis, and 11 encap-
sulated optochin-sensitive S. pneumoniae strains, and with 49
optochin-resistant streptococci of uncertain identities. A com-
plete list of the optochin-resistant strains and their reactions
are given in Table 1.
The phenotypic identification techniques used were op-
tochin susceptibility, bile solubility, and encapsulation. The
genotypic identification methods used were amplification of
the pneumolysin gene (ply), the autolysin gene (lytA), and the
pneumococcal surface antigen A gene (psaA); hybridization
with 16S rRNA (the AccuProbe test); and RsaI restriction of
the amplified 16S rRNA gene (ARDRA).
For the group of phenotypically well-identified S. mitis, S.
oralis, and S. pneumoniae strains, the results of all phenotypic
and genotypic techniques were in agreement with published
data. S. mitis and S. oralis were optochin resistant, unencapsu-
lated, bile insoluble, and negative by the AccuProbe test; gave
no amplification with ply-, lytA-, and psaA-specific primers; and
revealed the mitis group-specific RsaI ARDRA pattern (re-
striction fragments of 114, 146, 262, 355, and 625 bp). The S.
pneumoniae strains, however, had opposite characteristics and
a different RsaI restriction pattern, composed of fragments of
114, 146, 335, and 887 bp. The latter pattern was also observed
for the two S. sanguinis isolates tested.
For a better understanding, the 49 optochin-resistant pneu-
mococcus-like strains were split into a group consisting of the
11 encapsulated strains (group I) and a group consisting of the
remaining 38 strains, of which 35 were nonencapsulated and 3
had a weak Quellung reaction (group II). The group II strains
were further subdivided into groups IIa, IIb, and IIc, according
to their reactions by the different genotypic tests.
For the group I isolates (optochin resistant and encapsulat-
ed), the results obtained by all other techniques were positive,
pointing to an unequivocal identification as S. pneumoniae.
The seven optochin-resistant, nonencapsulated isolates of
group IIa were positive by the AccuProbe test and had an
ARDRA pattern typical for S. pneumoniae (ARDRA posi-
tive), although five isolates were negative by all three pheno-
typic assays and two were only bile soluble. Six of the seven
strains were also positive for ply, and four of seven of the
isolates had a weakly positive lytA amplification signal.
The 11 optochin-resistant, nonencapsulated isolates in group
IIb were positive only by the ply-specific PCR and/or bile pos-
itive. Four isolates also showed a weak positive reaction by the
lytA-specific PCR.
For the 20 optochin-resistant, nonencapsulated isolates of
group IIc, all techniques pointed to an identification as non-
pneumococci.
In conclusion, all optochin-resistant and encapsulated iso-
lates (group I) were identified as pneumococci by all other
phenotypic and genotypic techniques. Twenty of the 38 op-
tochin-resistant, unencapsulated isolates (group IIc) were
identified as nonpneumococci by all techniques, but 18 of the
38 optochin-resistant, nonencapsulated isolates (groups IIa
and IIb) could not be unequivocally identified, due to the
contradicting results of the phenotypic and genotypic tests.
The results of RsaI restriction of the amplified 16S rDNA
were always in agreement with the results obtained with the
AccuProbe system, and the psaA-specific PCR result was al-
ways in agreement with encapsulation.
DISCUSSION
Susceptibility to optochin is a cornerstone in the phenotypic
identification of pneumococci and is often used in laboratories
as the primary and sometimes the only identification method
(21). The occurrence of optochin-resistant S. pneumoniae
strains, which can result from mutations in the H-ATPase
(11), is not uncommon (2, 10, 21, 25, 26, 28), jeopardizing the
detection and correct identification of pneumococci. Other
problems with optochin susceptibility testing may be caused by
alpha-hemolytic streptococci and aerococci, which show small
zones of inhibition around optochin disks (23). Besides op-
tochin susceptibility testing, several problems exist with other
phenotypic tests for the identification of pneumococci (1, 7, 10,
23, 25, 27). An extensive comparison of the available biochem-
ical and serological methods was published recently, and that
analysis pointed to the high degrees of sensitivity but limited
specificities of most of the phenotypic tests (20).
The capsular reaction is sometimes difficult to interpret, as
was the case for two AccuProbe test-negative strains and one
AccuProbe test-positive strain included in the present study.
To simplify the discussion, these three strains were considered
unencapsulated, and therefore, in this study only strong cap-
sular swelling was considered indicative of an identification as
S. pneumoniae.
This study was set up to evaluate which of some of the
recently described genotypic techniques for the identification
of pneumococci are best suited for the unambiguous identifi-
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cation of a series of 49 strains that were sent to KTL in recent
years for serotyping or because they were “possibly pneumo-
coccal.”
The results of this study can be summarized as follows. The
group I and group IIc isolates posed no identification prob-
lems. Although the 11 group I isolates are optochin resistant,
they were readily recognized as pneumococci by the presence
of a capsule, by AccuProbe assay positivity, and by a positive
psaA-specific PCR result. Group IIc isolates were readily iden-
tified as nonpneumococcal alpha-hemolytic streptococci since
they were negative by all phenotypic and genotypic methods
applied in this study.
Taking into account all of the tests carried out, one is in-
clined to consider the group IIa and IIb isolates to be non-
pneumococcal alpha-hemolytic streptococci which, however,
show one or more characteristics of pneumococci. Most prob-
lematic were the positive results by the AccuProbe assay (con-
firmed by ARDRA) for the seven group IIa isolates. Group IIa
isolates showed several other reactions characteristic of those
of pneumococci, like positivity by the ply- and lytA-specific
PCRs and bile solubility, but all were unencapsulated and
psaA-specific PCR negative. The isolates in group IIb were
only ply-specific PCR positive and/or bile soluble, and four
group IIb isolates also showed a weak positive reaction by the
lytA-specific PCR.
This prompted us to consider the specificity of the Accu-
Probe test, which has been used as a “gold standard” for the
identification of pneumococci in several studies (6, 37).
Comparison of all 16S rRNA sequences of the S. mitis group
species showed that S. pneumoniae and S. sanguinis lack a RsaI
restriction site (GTAC) at Escherichia coli position 635, which
is present in S. mitis, S. oralis, and S. parasanguinis. S. sanguinis
is a species for which RsaI digestion of the 16S rDNA results
in a pattern that is similar to that for S. pneumoniae but that is
due to another point mutation. At E. coli position 635, the
sequences are GTAG in S. pneumoniae and GTAT in S. san-
guinis. We found complete concordance between the results of
the AccuProbe test and ARDRA, probably because the Accu-
Probe test targets the same region as ARDRA with RsaI di-
gestion. This points to the possibility that digestion of ampli-
fied 16S rDNA with RsaI could be a valuable and cheaper
alternative for differentiation between pneumococci and non-
pneumococcal streptococci, although the false-positive results
for S. sanguinis isolates must be taken into account.
Although the AccuProbe test and RsaI digestion of 16S
rDNA appear to enable identification of all genuine S. pneu-
moniae isolates, the possibility that closely related nonpneu-
mococcal S. mitis strains have (nearly) identical 16S rDNAs,
resulting in false-positive AccuProbe test and ARDRA results,
cannot be excluded. On the basis of all data gathered in the
present study and in the study of Whatmore et al. (37), we
believe that not only the AccuProbe test-negative group IIb
strains but also the AccuProbe test-positive group IIa strains
are indeed not pneumococci. Mundy et al. (25) also reported
that of 115 atypical pneumococci with inconsistent combina-
tions of optochin susceptibilities, tube bile solubilities, and
Quellung reactions, 33 reacted by the AccuProbe assay. Of
these 33 isolates, only 3 showed a capsule that reacted in the
Quellung test. All group IIa strains were isolated from the
upper respiratory tract and not from patients with invasive
disease. Whatmore et al. (37) conclude, “Our results indicated
that many of the isolates identified as pneumococci by Accu-
Probe could actually represent organisms which are genetically
rather divergent from typical pneumococci.”
The probable close evolutionary relationship between gen-
uine and atypical pneumococci and the sporadic horizontal
transfer of some pneumococcal genes to their closest relatives
may explain the existence of nonpneumococcal S. mitis cluster
strains with a pneumococcal 16S rDNA sequence and with
sporadic pneumococcal genes, and this may be an explanation
for the identification problems posed by such atypical pneu-
mococci.
Although we tend to consider most of the atypical pneumo-
coccus isolates of group IIa to be nonpneumococcal isolates,
despite a positive AccuProbe test result, it may be prudent to
treat these isolates as pneumococcal isolates anyway, since they
can harbor some pneumococcal virulence genes. In this study,
the presence of several pneumococcal virulence genes in the
AccuProbe test-positive nonpneumococcal S. mitis cluster
strains was obvious, and Whatmore et al. (37) also described
the existence of pathogenic S. mitis strains harboring the vir-
ulence determinants pneumolysin and autolysin, which are
classically associated with S. pneumoniae. Fortunately, the
presence of one or another pneumococcal virulence gene
seems to coincide in many cases with a positive AccuProbe test
result; therefore, the AccuProbe assay could be continued to
be used as the gold standard for the detection of pneumococcal
virulence genes.
Although Jado et al. (15) reported that the psaA gene could
be amplified from isolates of S. mitis, S. oralis, and S. anginosus
with their primers, the primers described by Morrison et al.
(24), which enabled amplification of the psaA gene from all 90
serotypes of S. pneumoniae and which were used in this study,
appear to be very specific for S. pneumoniae. The psaA gene
was amplified with the primers of Morrison et al. (24) only
from genuine pneumococci and the optochin-resistant but en-
capsulated pneumococci of group I. This positivity by the psaA-
specific PCR always corresponded to encapsulation.
In conclusion, the results presented here indicate that iden-
tification problems continue to exist for some strains, despite
the application of combined genotypic and phenotypic tests.
On the basis of our observations and those of other research-
ers, we propose that the following recommendations be put
into practice in our laboratories and be considered by other
researchers. The optochin sensitivity test, when performed
carefully, is the standard method for the identification of pneu-
mococci. An optochin-sensitive alpha-hemolytic Streptococcus
is almost always a pneumococcus. For optochin-resistant iso-
lates, the presence or absence of a capsule should be verified
by the Quellung reaction or the counterimmunoelectrophore-
sis method, if, on the basis of the origin (e.g., blood or cere-
brospinal fluid) or the colony morphology (e.g., a slimy colony)
of the isolate, there is a good reason to suspect the presence of
pneumococci. An optochin-resistant, encapsulated bacterium
is then identified as a pneumococcus. Since we found in this
study that a positive result by the psaA-specific PCR with the
primers described by Morrison et al. (24) is in perfect corre-
spondence with encapsulation, this genotypic technique is best
suited for the identification of genuine pneumococci and
can possibly replace both the optochin sensitivity test and the
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Quellung reaction. The AccuProbe test was considered to be
somewhat less specific than the psaA-specific PCR, but the
AccuProbe test result largely coincided with the presence of
pneumococcal virulence genes in nonpneumococci, and it
therefore retains its value. Digestion of amplified 16S rDNA
with RsaI (ARDRA) is a cheap and valuable alternative to the
AccuProbe test. Amplification of the pneumolysin gene (ply-
specific PCR) and the autolysin gene (lytA-specific PCR) is
somewhat less specific than the AccuProbe test and probably
leads to overestimation of the number of pneumococcal infec-
tions. Even though genotypic methods provide new possibili-
ties for the identification of pneumococci, it is obvious that due
to the presence of pneumococcal virulence genes in nonpneu-
mococcal S. mitis isolates, it is not always easy to draw a clear
line between pneumococcal and nonpneumococcal isolates.
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